User profiles for Patrick B Ryan
Patrick RyanJanssen Research and Development Verified email at cornell.edu Cited by 13315 |
[HTML][HTML] Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers
The vision of creating accessible, reliable clinical evidence by accessing the clinical
experience of hundreds of millions of patients across the globe is a reality. The Observational …
experience of hundreds of millions of patients across the globe is a reality. The Observational …
Validation of a common data model for active safety surveillance research
JM Overhage, PB Ryan, CG Reich… - Journal of the …, 2012 - academic.oup.com
Objective Systematic analysis of observational medical databases for active safety surveillance
is hindered by the variation in data models and coding systems. Data analysts often find …
is hindered by the variation in data models and coding systems. Data analysts often find …
Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership
PE Stang, PB Ryan, JA Racoosin… - Annals of internal …, 2010 - acpjournals.org
The US Food and Drug Administration (FDA) Amendments Act of 2007 mandated that the
FDA develop a system for using automated health care data to identify risks of marketed drugs …
FDA develop a system for using automated health care data to identify risks of marketed drugs …
Characterizing treatment pathways at scale using the OHDSI network
Observational research promises to complement experimental research by providing large,
diverse populations that would be infeasible for an experiment. Observational research can …
diverse populations that would be infeasible for an experiment. Observational research can …
Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis
Background Uncertainty remains about the optimal monotherapy for hypertension, with current
guidelines recommending any primary agent among the first-line drug classes thiazide or …
guidelines recommending any primary agent among the first-line drug classes thiazide or …
Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study
Objective To quantify the background incidence rates of 15 prespecified adverse events of
special interest (AESIs) associated with covid-19 vaccines. Design Multinational network …
special interest (AESIs) associated with covid-19 vaccines. Design Multinational network …
Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non‐SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with …
Aims Sodium glucose co‐transporter 2 inhibitors (SGLT2i) are indicated for treatment of type
2 diabetes mellitus (T2DM); some SGLT2i have reported cardiovascular benefit, and some …
2 diabetes mellitus (T2DM); some SGLT2i have reported cardiovascular benefit, and some …
Feasibility and utility of applications of the common data model to multiple, disparate observational health databases
… Patrick B Ryan Patrick B Ryan … Erica A Voss, Rupa Makadia, Amy Matcho, Qianli Ma,
Chris Knoll, Martijn Schuemie, Frank J DeFalco, Ajit Londhe, Vivienne Zhu, Patrick B Ryan, …
Chris Knoll, Martijn Schuemie, Frank J DeFalco, Ajit Londhe, Vivienne Zhu, Patrick B Ryan, …
Association of ticagrelor vs clopidogrel with net adverse clinical events in patients with acute coronary syndrome undergoing percutaneous coronary intervention
Importance Current guidelines recommend ticagrelor as the preferred P2Y12 platelet
inhibitor for patients with acute coronary syndrome (ACS), primarily based on a single large …
inhibitor for patients with acute coronary syndrome (ACS), primarily based on a single large …
[HTML][HTML] Renin–angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis
Background Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor
blockers (ARBs) have been postulated to affect susceptibility to COVID-19. Observational …
blockers (ARBs) have been postulated to affect susceptibility to COVID-19. Observational …